Boston Scientific Introduces The Expect™ Slimline (SL) Needle For Use During Endoscopic Ultrasound Fine Needle Aspiration Procedures

Boston Scientific Corporation (NYSE:BSX) has received clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval in Europe for the Expect™ Slimline (SL) Needle, which is now globally available for Endoscopic Ultrasound-Fine Needle Aspiration (EUS-FNA) procedures.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news